NEW YORK (GenomeWeb News) – Natera today announced it has reached a deal with DiagCor to launch Natera's non-invasive prenatal screening test in Hong Kong.

DiagCor is based in Hong Kong and provides molecular diagnostic testing to doctors and healthcare professionals in the region.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.